Article
FGF23 is a potential prognostic biomarker in uterine sarcoma
2023-08-23
Abstract excerpt
<h4>Background</h4> Uterine sarcoma (US) is a highly malignant cancer with poor prognosis and high mortality in women. In this study, we evaluated the expression of human fibroblast growth factor 23 (FGF23) in different US subtypes and the relationship between survival and clinicopathological characteristics. <h4>Methods</h4> We conducted a comparative analysis of FGF23 gene expression in different pathological ty...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bdcdbc22-c2c6-5456-93ce-32de32583d42
- DOI
- 10.1101/2023.08.20.23294198
